FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306407510> ?p ?o ?g. }

• W4306407510 endingPage "152106" @default.
• W4306407510 startingPage "152106" @default.
• W4306407510 abstract "Objective No guidelines exist for Pneumocystis jirovecii pneumonia (PJP) prophylaxis in patients with systemic lupus erythematosus (SLE). Limited data are available on incidence of PJP infection and use of PJP prophylaxis. Using a real-world, electronic health record (EHR) cohort, we investigated the frequency of PJP infections as well as patient and provider factors that impacted use and type of PJP prophylaxis. Methods In a large, de-identified EHR, we identified possible SLE patients using a previously validated algorithm. PJP ICD-9 or ICD-10-CM billing codes and PJP keywords were used to identify possible PJP cases within this SLE cohort. We assessed for PJP prophylaxis prescribing in all SLE patients using keywords and reviewing medication lists for prophylactic agents. Chart review was used to confirm cases of SLE, PJP, and PJP prophylaxis and to obtain data on demographics, comorbidities, and immunosuppressants. Results Of 977 SLE patients, there were only four with confirmed PJP infection. Two of these patients had concurrent Acquired Immunodeficiency Syndrome, and none were on prophylaxis. Of 977 SLE patients, 132 (14%) were prescribed PJP prophylaxis. Of 617 SLE patients ever prescribed immunosuppressants, 128 (21%) were prescribed PJP prophylaxis. Sulfonamides were the most common prophylaxis prescribed (69%), and possible adverse events were documented in 22 out of 117 instances of being placed on a sulfonamide. Patients of younger age, Black race, nephritis, and renal transplant, and on chronic glucocorticoids were all more likely to have PJP prophylaxis prescribed. Patients who were on transplant induction medications, calcineurin/mTOR inhibitors, cyclophosphamide, and mycophenolate mofetil all were more likely to be prescribed PJP prophylaxis compared to other immunosuppressants. Conclusion PJP is a rare diagnosis among SLE patients, and prior studies may even overestimate its prevalence. PJP prophylaxis was less common in our cohort than previously described. Adverse events related to sulfonamides used for PJP prophylaxis were relatively rare with lower rates than previously reported. Our study demonstrates real-world PJP prophylaxis prescribing patterns in a large cohort of SLE patients." @default.
• W4306407510 created "2022-10-17" @default.
• W4306407510 creator A5016504310 @default.
• W4306407510 creator A5025138906 @default.
• W4306407510 creator A5044083508 @default.
• W4306407510 creator A5069740051 @default.
• W4306407510 creator A5083937269 @default.
• W4306407510 date "2022-12-01" @default.
• W4306407510 modified "2023-09-29" @default.
• W4306407510 title "Rates of Pneumocystis jirovecii pneumonia and prophylaxis prescribing patterns in a large electronic health record cohort of patients with systemic lupus erythematosus" @default.
• W4306407510 cites W1924333547 @default.
• W4306407510 cites W1975599820 @default.
• W4306407510 cites W1976692122 @default.
• W4306407510 cites W1989233978 @default.
• W4306407510 cites W2003835506 @default.
• W4306407510 cites W2006776184 @default.
• W4306407510 cites W2011589611 @default.
• W4306407510 cites W2064364188 @default.
• W4306407510 cites W2159636537 @default.
• W4306407510 cites W2310274426 @default.
• W4306407510 cites W2398372911 @default.
• W4306407510 cites W2474029657 @default.
• W4306407510 cites W2483963880 @default.
• W4306407510 cites W2612998283 @default.
• W4306407510 cites W2654839484 @default.
• W4306407510 cites W2766715376 @default.
• W4306407510 cites W2788740023 @default.
• W4306407510 cites W2899090069 @default.
• W4306407510 cites W2902970284 @default.
• W4306407510 cites W2908483662 @default.
• W4306407510 cites W2951264388 @default.
• W4306407510 cites W2959499398 @default.
• W4306407510 cites W2972354417 @default.
• W4306407510 cites W2980382406 @default.
• W4306407510 cites W3112259624 @default.
• W4306407510 cites W3129543536 @default.
• W4306407510 cites W3135144631 @default.
• W4306407510 cites W3184055878 @default.
• W4306407510 cites W795008685 @default.
• W4306407510 doi "https://doi.org/10.1016/j.semarthrit.2022.152106" @default.
• W4306407510 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36279805" @default.
• W4306407510 hasPublicationYear "2022" @default.
• W4306407510 type Work @default.
• W4306407510 citedByCount "3" @default.
• W4306407510 countsByYear W43064075102023 @default.
• W4306407510 crossrefType "journal-article" @default.
• W4306407510 hasAuthorship W4306407510A5016504310 @default.
• W4306407510 hasAuthorship W4306407510A5025138906 @default.
• W4306407510 hasAuthorship W4306407510A5044083508 @default.
• W4306407510 hasAuthorship W4306407510A5069740051 @default.
• W4306407510 hasAuthorship W4306407510A5083937269 @default.
• W4306407510 hasBestOaLocation W43064075102 @default.
• W4306407510 hasConcept C120665830 @default.
• W4306407510 hasConcept C121332964 @default.
• W4306407510 hasConcept C126322002 @default.
• W4306407510 hasConcept C2776912625 @default.
• W4306407510 hasConcept C2777914695 @default.
• W4306407510 hasConcept C2778602436 @default.
• W4306407510 hasConcept C2779134260 @default.
• W4306407510 hasConcept C2779912601 @default.
• W4306407510 hasConcept C501593827 @default.
• W4306407510 hasConcept C61511704 @default.
• W4306407510 hasConcept C71924100 @default.
• W4306407510 hasConcept C72563966 @default.
• W4306407510 hasConcept C86803240 @default.
• W4306407510 hasConcept C89423630 @default.
• W4306407510 hasConceptScore W4306407510C120665830 @default.
• W4306407510 hasConceptScore W4306407510C121332964 @default.
• W4306407510 hasConceptScore W4306407510C126322002 @default.
• W4306407510 hasConceptScore W4306407510C2776912625 @default.
• W4306407510 hasConceptScore W4306407510C2777914695 @default.
• W4306407510 hasConceptScore W4306407510C2778602436 @default.
• W4306407510 hasConceptScore W4306407510C2779134260 @default.
• W4306407510 hasConceptScore W4306407510C2779912601 @default.
• W4306407510 hasConceptScore W4306407510C501593827 @default.
• W4306407510 hasConceptScore W4306407510C61511704 @default.
• W4306407510 hasConceptScore W4306407510C71924100 @default.
• W4306407510 hasConceptScore W4306407510C72563966 @default.
• W4306407510 hasConceptScore W4306407510C86803240 @default.
• W4306407510 hasConceptScore W4306407510C89423630 @default.
• W4306407510 hasFunder F4320306222 @default.
• W4306407510 hasFunder F4320306673 @default.
• W4306407510 hasFunder F4320308971 @default.
• W4306407510 hasFunder F4320332161 @default.
• W4306407510 hasFunder F4320337362 @default.
• W4306407510 hasFunder F4320337375 @default.
• W4306407510 hasFunder F4320337472 @default.
• W4306407510 hasLocation W43064075101 @default.
• W4306407510 hasLocation W43064075102 @default.
• W4306407510 hasLocation W43064075103 @default.
• W4306407510 hasOpenAccess W4306407510 @default.
• W4306407510 hasPrimaryLocation W43064075101 @default.
• W4306407510 hasRelatedWork W2098134050 @default.
• W4306407510 hasRelatedWork W2275480158 @default.
• W4306407510 hasRelatedWork W2482503989 @default.
• W4306407510 hasRelatedWork W2603773853 @default.
• W4306407510 hasRelatedWork W2808337530 @default.
• W4306407510 hasRelatedWork W2944506432 @default.

• next